StockData
Phibro Animal Health Corp logo

Phibro Animal Health Corp (PAHC) stock

PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 22/3045% below fair value
$35.57+0.65 (+1.86%)

Close on Nov 18, 2026Market cap $1.44BP/E 14.6Yield 1.35%

Phibro Animal Health revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Phibro Animal Health's revenue for the twelve months ending Jun 30, 2026 was $1.52B, up 17.1% year over year. For fiscal 2026 it was $1.52B, up 17.1% from the year before. Over ten years it grew 7.3% a year on average. The highest annual figure on record is $1.52B in fiscal 2026.

Annual revenue

PeriodPeriod endValueChange
FY2026Jun 30, 2026$1.52B+17.1%
FY2025Jun 30, 2025$1.30B+27.4%
FY2024Jun 30, 2024$1.02B+4.1%
FY2023Jun 30, 2023$977.89M+3.8%
FY2022Jun 30, 2022$942.26M+13.1%
FY2021Jun 30, 2021$833.35M+4.1%
FY2020Jun 30, 2020$800.35M-3.3%
FY2019Jun 30, 2019$828.00M+1.0%
FY2018Jun 30, 2018$819.98M+7.3%
FY2017Jun 30, 2017$764.28M+1.7%
FY2016Jun 30, 2016$751.53M+0.4%
FY2015Jun 30, 2015$748.59M+8.2%
FY2014Jun 30, 2014$691.91M+5.9%
FY2013Jun 30, 2013$653.15M-0.1%
FY2012Jun 30, 2012$654.10M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$396.75M+4.8%
Q3 FY2026CQ1 2026Mar 31, 2026$383.54M+10.3%
Q2 FY2026CQ4 2025Dec 31, 2025$373.91M+20.9%
Q1 FY2026CQ3 2025Sep 30, 2025$363.89M+39.7%
Q4 FY2025CQ2 2025Jun 30, 2025$378.70M+38.6%
Q3 FY2025CQ1 2025Mar 31, 2025$347.83M+32.1%
Q2 FY2025CQ4 2024Dec 31, 2024$309.26M+23.7%
Q1 FY2025CQ3 2024Sep 30, 2024$260.43M+12.6%
Q4 FY2024CQ2 2024Jun 30, 2024$273.16M+7.1%
Q3 FY2024CQ1 2024Mar 31, 2024$263.22M+7.1%
Q2 FY2024CQ4 2023Dec 31, 2023$249.94M+2.2%
Q1 FY2024CQ3 2023Sep 30, 2023$231.35M-0.5%
Q4 FY2023CQ2 2023Jun 30, 2023$255.05M-0.1%
Q3 FY2023CQ1 2023Mar 31, 2023$245.67M+2.5%
Q2 FY2023CQ4 2022Dec 31, 2022$244.65M+5.1%
Q1 FY2023CQ3 2022Sep 30, 2022$232.52M+8.3%
Q4 FY2022CQ2 2022Jun 30, 2022$255.27M+15.9%
Q3 FY2022CQ1 2022Mar 31, 2022$239.62M+13.2%
Q2 FY2022CQ4 2021Dec 31, 2021$232.71M+12.9%
Q1 FY2022CQ3 2021Sep 30, 2021$214.67M+10.0%
Q4 FY2021CQ2 2021Jun 30, 2021$220.28M+18.5%
Q3 FY2021CQ1 2021Mar 31, 2021$211.73M+0.5%
Q2 FY2021CQ4 2020Dec 31, 2020$206.15M-3.7%
Q1 FY2021CQ3 2020Sep 30, 2020$195.19M+2.9%
Q4 FY2020CQ2 2020Jun 30, 2020$185.88M-8.8%
Q3 FY2020CQ1 2020Mar 31, 2020$210.74M+2.4%
Q2 FY2020CQ4 2019Dec 31, 2019$214.01M-1.9%
Q1 FY2020CQ3 2019Sep 30, 2019$189.72M-5.2%
Q4 FY2019CQ2 2019Jun 30, 2019$203.88M-3.7%
Q3 FY2019CQ1 2019Mar 31, 2019$205.74M-1.5%
Q2 FY2019CQ4 2018Dec 31, 2018$218.22M+6.0%
Q1 FY2019CQ3 2018Sep 30, 2018$200.15M+3.5%
Q4 FY2018CQ2 2018Jun 30, 2018$211.79M+8.7%
Q3 FY2018CQ1 2018Mar 31, 2018$208.91M+10.0%
Q2 FY2018CQ4 2017Dec 31, 2017$205.88M+7.5%
Q1 FY2018CQ3 2017Sep 30, 2017$193.41M+2.9%
Q4 FY2017CQ2 2017Jun 30, 2017$194.84M–
Q3 FY2017CQ1 2017Mar 31, 2017$189.86M–
Q2 FY2017CQ4 2016Dec 31, 2016$191.60M–
Q1 FY2017CQ3 2016Sep 30, 2016$187.99M–

More Phibro Animal Health figures

See a number that looks wrong?